IFNG and carcinoma: These single-cell analyses of carcinoma cells within MOC22 tumors supports early loss of tumor cell viability and enhanced tumor cell immunogenicity through increased expression of IFN-γ–responsive genes following treatment with i.t. NHS–rmIL-12.